Atorvastatin in the secondary prevention of cardiovascular diseases
Clinical manifestations of the atherosclerotic process are leading causes of mortality, morbidity and disability in the adult population of the developed countries all over the world. Many years of research have established a clear relationship between the risk of cardiovascular disease and high cho...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2014-12-01
|
| Series: | Медицинский совет |
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/666 |
| Summary: | Clinical manifestations of the atherosclerotic process are leading causes of mortality, morbidity and disability in the adult population of the developed countries all over the world. Many years of research have established a clear relationship between the risk of cardiovascular disease and high cholesterol level. Numerous global epidemiological studies, such as, for example, the Framingham Heart Study [1] and INTERHEART [2], provided solid evidence confirming that statement. Moreover, randomized clinical trials of lipid-lowering interventions over the past 10-15 years demonstrate that greater cholesterol reduction is associated with a significant decrease in the risk of complications. |
|---|---|
| ISSN: | 2079-701X 2658-5790 |